Not sure how much is panic selling or just the conversion of warrants & options- Per the 10K- Forgetting the most recent quarter that ended Feb. 29th, subsequently from March 1st to April 6, 29,357,527 shares were issued in connection to the exercise of warrants/options resulting in proceeds of $7.4 million- Or approximately .25cts per conversion- Thats a sweetheart deal, quick 10 bagger
Over on Happy Hangout board they're is a mildly heated debate about future PPS & buy-out numbers - of course ranging from $5/8 to $100 -- Regardless of the figure mentioned, nobody took into consideration that the most important factor to valuation is simply BEING on the NASDAQ.
For biotech stocks you can throw out any conventional valuation methodologies as it's truly a future "story" that's being sold. However two things that nearly every pre-revenue company have ( priced over $30) is a healthy relationship of cash on hand in relation to shares outstanding. It's uncommon the see these companies with less than $100 million in cash and more than 40 million in OS--
So along with up listing we have to somehow flip the numbers we're now saddled with - Hate to see us crossover with 600+ O/S. - but another partnership and the conversion of many of the remaining 140 million or so warrants/options would pad the account by $100 million+-- Which we'll need since we're now burning $7 million monthly and have substantial payments due to Samsung
Our story is still early & unfolding, so dream on-
News 
Market Data 
Discover 
AI
